# The Fifth INTEnsive pReventing Secondary Injury in Acute Cerebral Haemorrhage Trial Within ACT-GLOBAL

> **NCT06763055** · PHASE3 · RECRUITING · sponsor: **The George Institute** · enrollment: 2000 (estimated)

## Conditions studied

- Intracerebral Hemorrhage
- Spontaneous Intracerebral Hemorrhage
- Supratentorial Intracerebral Haemorrhage
- Acute Intracerebral Haemorrhage
- Acute Stroke

## Interventions

- **DRUG:** Colchicine 0.5 mg
- **DRUG:** Deferoxamine Mesylate
- **OTHER:** Control (Standard treatment)

## Key facts

- **NCT ID:** NCT06763055
- **Lead sponsor:** The George Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-27
- **Primary completion:** 2028-01
- **Final completion:** 2028-01
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2025-04-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06763055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06763055, "The Fifth INTEnsive pReventing Secondary Injury in Acute Cerebral Haemorrhage Trial Within ACT-GLOBAL". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06763055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*